Cure My Disease

Don't miss your cure!

 Log in / Sign up

New drug EDG-15400 tested in healthy people for first time

NCT ID NCT07177066

Recruiting now Knowledge-focused Sponsor: Edgewise Therapeutics, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This early-stage study is testing a new oral drug called EDG-15400 in 108 healthy adults aged 18 to 59. The main goal is to check if the drug is safe and how well it is tolerated, both after a single dose and after multiple doses. Researchers will also measure how much of the drug gets into the blood and urine, and whether food or the form of the drug (tablet vs. liquid) changes those levels. This is a Phase 1 trial, so it is focused on safety and drug behavior, not on treating any disease.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

EDG-15400 (oral drug)

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY ADULTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEALTHY ADULTS

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Celerion, Inc.

    RECRUITING

    Tempe, Arizona, 85283, United States

    Contact Phone: •••-•••-••••